Embolization, Inc., a medical device company based in Boulder, Colorado, announced its nitinol-enhanced device (NED) has ...

Vivasure Medical announced that it has received European CE Mark approval for an expanded indication for its fully bioresorbable, ...

Gore & Associates announced that the company’s TAG thoracic branch endoprosthesis (TBE) has received FDA approval for us ...

AngioDynamics, Inc. announced first patient enrollment in the RECOVER-AV clinical trial. The prospective, multicenter, multination ...

Endovascular Engineering, Inc. (E2) announced the completion of patient enrollment in the pivotal cohort of the ENGULF investigati ...

Gore & Associates: Gore Viabahn Endoprosthesis With Heparin Bioactive Surface Nitinol/ePTFE, gold: 6–10: 0.018/0.014 (5–8 mm), 0.035 (5–13 mm) ...

Teleflex: Manta Vascular Closure Device Bioresorbable implant: Following the use of 10–20 F device or sheaths (12–25 F OD) 0.035: Indicated for closure of femoral artery access sites while reducing ...

Silk Road Medical: Enroute Transcarotid Neuroprotection System Robust flow reversal: Proximal: Intended to provide transcarotid vascular access, introduction of diagnostic agents and therapeutic ...

Dr. Fukaya shares tips for a patient-centered venous disease practice, challenges facing the vascular medicine field, where ...

TRAINING IN ENDOVASCULAR SURGERY DURING THE MECHANICAL THROMBECTOMY (MT) INNOVATION BOOM. I was fortunate to have completed ...

A summary of preclinical evaluation methods for neuroendovascular devices, including in vitro techniques, 3D-printed vascular models, in silico simulations, and in vivo models.